Search

Search Constraints

You searched for: Author/Creator Rivero, Montserrat

Search Results

1. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Issue 11 (18th October 2019)

2. Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry. Issue 11 (22nd April 2019)

3. Changes in the requirement for early surgery in inflammatory bowel disease in the era of biological agents. Issue 12 (10th May 2020)

4. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis. Issue 8 (30th June 2017)

7. Effectiveness and safety of methotrexate monotherapy in patients with Crohn's disease refractory to anti‐TNF‐α: results from the ENEIDA registry. Issue 9 (14th March 2021)

8. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry. Issue 4 (29th August 2019)

9. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry. Issue 4 (4th March 2020)

10. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry. (1st August 2022)